Oracle's Dividend Hike Signals Confidence, But Cash Flow Still Under AI Capex Pressure

What happened

Oracle raised its annual dividend for the 12th consecutive year, lifting the payout to $2 per share while reiterating that earnings and backlog provide a cushion, even as AI-driven capex keeps free cash flow deeply negative. The increase is modest relative to Oracle's $55.7 billion FY2026 capex and its planned $40 billion FY2027 financing, which includes a $20 billion at-the-money equity program. The dividend is still covered by GAAP earnings with a payout ratio near 30%, but not by operating cash flow after capex, meaning it is effectively funded by borrowings and deferred dilution. Management is using the dividend to signal stability and capital-return confidence, yet the move does not change the core issue: only about 12% of Oracle's $638 billion backlog converts to revenue within 12 months, leaving cash conversion unproven. Investors should treat the dividend hike as a minor positive signal, not as evidence that Oracle's AI buildout has reached a self-funding phase.

Implication

For investors, the dividend increase should be read as a signal of board-level confidence in Oracle's earnings power, but not as a solution to the free-cash-flow deficit, which was -$23.7 billion in FY2026. The payout is modest at roughly $5.7 billion annually and is covered by GAAP earnings, yet it adds to cash needs at a time when Oracle plans to raise $40 billion in new financing, including up to $20 billion of equity through its ATM program. The key monitor remains Q1 FY2027 results and the next RPO timing disclosure: cloud growth must land within 58%–64% and 12-month backlog conversion must hold at or above 12% to avoid further de-rating. Any material ATM usage before operating cash flow inflects would signal that management is funding both the dividend and AI expansion with dilutive capital, which would be a negative for per-share value. Until Oracle shows customer prepayments rising or free cash flow approaching breakeven, the dividend offers no margin of safety and the stock is best rated WAIT rather than a buy.

Thesis delta

No material change to the WAIT thesis. The dividend increase signals board confidence but does not address the core cash-conversion gap, and it adds a modest annual cash obligation of $5.7 billion that must be financed alongside the AI buildout. The risk/reward remains unchanged: Oracle needs Q1 FY2027 cloud growth and RPO conversion to accelerate before the stock becomes attractive.